8/30/2025Recent Executive Moves

8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib

8/29/2025Eli Lilly Partners with JD Health for Popular Weight-Loss Medicines

8/29/2025Fosun Secures Exclusive Rights to ACCRO’s AC-201 in Greater China

8/29/2025Adcoris Raises CNY Tens of Millions to Advance Next-Gen ADC Programs

8/29/2025MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...

8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...

8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China

8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval

8/29/2025​​​​​​​CDE Issues Draft Requirements for Module 2 Chemistry Doc...

8/29/2025CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...

More>>

8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push

8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...

8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...

8/20/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

8/19/2025Six Key Insights Into China Biotech's NewCo Model (Mondaq)

8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...

8/19/2025Adjudication Of Drug Patent Linkage Cases When The Originator Drug's T...

8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...

8/14/2025China Sees Surge in Innovative Drug Approvals in H1, Covering Cancer, ...

8/13/2025The Trends Shaping Chinese Pharma Patent Litigation (Mondaq)

8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

More>>